Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The promastigote form of Leishmania donovani is sensitive to growth inhibition by DL-alpha-difluoromethylornithine (DFMO), an inhibitor of
ornithine decarboxylase
(
ODC
), the first enzyme of the polyamine biosynthetic pathway, with an EC50 value of approximately 30 microM. Exposure of a wild type (DI700) cell population to gradually increasing concentrations of DFMO resulted in the selection of a strain of Leishmania, DFMO-10, which was capable of proliferating in 10 mM DFMO. DFMO-10 cells possessed an EC50 value for DFMO greater than 4 mM, and were cross-resistant to alpha-methylornithine, alpha-monofluoromethyl-3,4-dehydroornithine methyl ester, and delta-methyl-acetylenic putrescine, three other inhibitors of
ODC
activity. DI700 and DFMO-10 cells accumulated and/or transported [3H]DFMO and a spectrum of basic, neutral, and acidic amino acids at comparative rates. However, the DFMO-resistant Leishmania, if suspended in culture medium in the absence of DFMO for several days, expressed up to 15-fold greater levels of
ODC
activity than did wild-type cells. The overexpressed
ODC
in mutant cells appeared kinetically normal, since the
ODC
activities from DI700 and DFMO-10 cells possessed similar apparent Km values for ornithine and were equally sensitive to inactivation by DFMO. Incubation of extracts of DFMO-10 cells, but not of wild-type parental cells, with [3H]DFMO for 1 h resulted in the labeling of a polypeptide, presumably
ODC
, which migrated with a molecular weight of 76,000 +/- 4000 on SDS-gel electrophoretograms. As a consequence of the elevated
ODC
activities, the levels of putrescine in mutant cells released from DFMO exposure were also elevated by about 15-fold over those of wild-type cells, although spermidine levels in DI700 and DFMO-10 cells were similar. In the absence of prolonged selective pressure, the resistance to DFMO, the
ODC
activity, and the putrescine levels of DFMO-10 cells all returned to those of wild type cells, indicating that the mutant phenotype of DFMO-selected L. donovani was unstable.
Mol
Biochem Parasitol 1990 Feb
PMID:Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity. 215 91
A single electroconvulsive shock (ECS) resulted in a major induction of cerebral
ornithine decarboxylase
(
ODC
) mRNA and a rapid and transient elevation of
ODC
enzyme activity. The proto-oncogene c-fos was also transiently induced under the same conditions. Following a rapid rise in mRNA levels, the messages for these proteins take different courses. The c-fos mRNA fell to below control levels by 1 h, while the
ODC
mRNA remained elevated beyond 24 h. The ECS-induced elevation of
ODC
enzyme activity was not abolished by adrenalectomy but was attenuated significantly by the anti-convulsant MK-801. These results imply that the induction of cerebral
ODC
may be neuronal activity dependent, and suggest that the
ODC
/polyamine system may be linked to the proposed third messenger cascade, involving c-fos, which couples cell stimulation to gene expression, resulting in long-term adaptive responses.
Brain Res
Mol
Brain Res 1990 Apr
PMID:Electrically stimulated rapid gene expression in the brain: ornithine decarboxylase and c-fos. 215 84
Electrical stimulation of the Schaffer-collateral axonal system under conditions which do not elicit detectable seizure activity causes an increase in the activity of
ornithine decarboxylase
(
ODC
), the rate limiting enzyme of polyamine synthesis, in the hippocampus, olfactory cortex, neocortex and olfactory bulb. The degree of
ODC
activation is dependent upon the stimulus parameters. The results support the hypothesis that neuronal activity regulates hippocampal polyamine concentrations.
Brain Res
Mol
Brain Res 1990 Feb
PMID:Induction of ornithine decarboxylase by subseizure stimulation in the hippocampus in vivo. 216 44
Stimulation of
ornithine decarboxylase
(
ODC
) activity was examined in cultured heart cells from neonatal rats. Fetal bovine serum had a concentration-dependent effect on
ODC
activity with maximum response obtained at 10% serum.
ODC
activity peaked 4 h after the addition of serum and returned to initial levels at 8 h. In the absence of serum, non-cytotoxic concentrations of the adrenergic agonists epinephrine, norepinephrine or isoproterenol did not stimulate
ODC
activity. Co-administration of serum and catecholamines at 10(-5) M induced an
ODC
response that was significantly greater than that induced by serum alone. A screen of various constituents of serum revealed that insulin, though relatively ineffective alone, acted cooperatively with catecholamines to produce an
ODC
response equivalent to that induced by 10% serum. Propranolol effectively blocked the cooperative effect of insulin on catecholamine stimulation of
ODC
activity, and markedly inhibited the stimulation of
ODC
by 10% serum. Insulin also acted cooperatively with the second-messenger analogue dibutyryl-cAMP. The calcium ionophore A23187 significantly increased
ODC
activity and this response was potentiated by the presence of insulin. The present findings are concordant with in vivo observations in that beta-adrenergic activation stimulates
ODC
activity in cultured heart cells, but it also demonstrates that the cooperative action of other factors present in serum, such as insulin, are required.
J
Mol
Cell Cardiol 1990 Jun
PMID:Cooperative action of insulin and catecholamines on stimulation of ornithine decarboxylase activity in neonatal rat heart cells. 217 54
We report the physical and genetic mapping of pheV, an Escherichia coli gene for phenylalanine tRNA, to 64 min on the chromosomal map in the near vicinity of speC coding for
ornithine decarboxylase
.
Mol
Gen Genet 1990 Jan
PMID:Genetic mapping of pheV, an Escherichia coli gene for tRNA(Phe). 218 6
Ornithine decarboxylase
(
ODC
) mRNA is strongly induced by mitogenic activation of resting Swiss 3T3 fibroblasts and T lymphocytes. Nuclear run-on analysis revealed a low level of nascent transcripts in resting fibroblasts that was elevated upon activation. In contrast, there was a high level of transcription across the entire
ODC
gene in resting T cells, which remained unchanged upon activation. The stability of the mature
ODC
message was found to be unaffected by mitogenic stimulation. These results indicate that
ODC
mRNA levels are regulated transcriptionally in Swiss 3T3 cells and posttranscriptionally within the nucleus of T lymphocytes in response to mitogenic stimuli. In this unique situation, the mitogenic induction of a single gene,
ODC
, is regulated by two very distinct, cell-specific mechanisms.
Mol
Cell Biol 1990 Oct
PMID:Cell type-specific mechanisms of regulating expression of the ornithine decarboxylase gene after growth stimulation. 220 17
Casein kinase II and
ornithine decarboxylase
were purified from a virally-transformed macrophage-like cell line, RAW264. The addition of casein kinase II to a reaction mixture containing [tau-32P]GTP, Mg++, and
ornithine decarboxylase
led to the phosphorylation of a 55,000 dalton protein band in the purified preparation of
ornithine decarboxylase
. Stoichiometric estimates indicated that casein kinase II incorporated 0.15 mole of phosphate per mole of
ornithine decarboxylase
, which was increased to 0.3 mole/per mole in the presence of spermine. The apparent Km and Vmax values for the casein kinase II-mediated phosphorylation of
ornithine decarboxylase
were 0.36 microM and 62.5 nmol/min./mg kinase. The addition of spermine to the reaction did not alter the Km but increased the Vmax to 100 nmol/min./mg kinase. The phosphorylation of
ornithine decarboxylase
by casein kinase II affected neither the rate of maximal
ornithine decarboxylase
activity nor the affinity of the enzyme for ornithine.
Cell
Mol
Biol 1990
PMID:Phosphorylation of ornithine decarboxylase by casein kinase II from RAW264 cells. 222 53
Recent evidence indicates that the polyamine pathway may play a significant role in the autocrine/paracrine control of breast cancer cell proliferation by hormones. To directly test this hypothesis, in the present experiments, we evaluated the polyamine involvement in immunoactive insulin-like growth factor I (IGF-I) secretion and IGF-I action using MCF-7 breast cancer cells cultured in serum-free medium in the presence and absence of estradiol (E2). Administration of the polyamine biosynthetic inhibitor, alpha-difluoromethylornithine (DFMO) induced a marked suppression of cellular
ornithine decarboxylase
(
ODC
) activity and polyamine levels which was associated with significant, although partial, inhibition of E2-stimulated growth. Exogenous putrescine administration repleted cellular polyamine pools and completely reversed the growth-inhibitory effect of DFMO. Despite these parallel changes in polyamine levels and proliferative activity, basal as well as E2-stimulated levels of immunoactive IGF-I measured in the conditioned media were unaffected by DFMO with and without exogenous putrescine administration. On the other hand, induction of polyamine depletion and repletion by the same treatments significantly (although partially) affected the proliferative action of exogenously added IGF-I. These findings indicate that polyamines, while not involved in immunoactive IGF-I production, play an important role, at least in part, in IGF-I action in this experimental system. Furthermore, we observed that the administration of a monoclonal antibody directed against IGF-I was able to partially block basal as well as of a monoclonal antibody directed against IGF-I was able to partially block basal as well as E2-stimulated MCF-7 cell proliferation. We conclude that immunoactive IGF-I is an important but not sole mediator of MCF-7 breast cancer growth under our experimental conditions. The polyamine pathway plays an important role in the expression of its proliferative action.
J Steroid Biochem
Mol
Biol 1990 Sep
PMID:Polyamine involvement in basal and estradiol-stimulated insulin-like growth factor I secretion and action in breast cancer cells in culture. 224 41
Ornithine decarboxylase
(
ODC
) is an enzyme that has been shown to be induced in the growth, differentiation and proliferation of cells. We have used a cDNA probe to determine
ODC
mRNA levels in different stages of the cycle of rat and mouse seminiferous epithelium. For Northern and slot-blot hybridizations, RNA was isolated from microdissected staged seminiferous tubules. Cell-specific localization of
ODC
mRNA was studied by in situ hybridization. In the rat, in situ hybridization showed increasing mRNA levels during prophase of meiosis with the highest mRNA levels seen in late pachytene spermatocytes and step 3-5 spermatids. In the mouse, the mRNA levels increased in a similar fashion and the highest mRNA levels were found in step 1-8 spermatids. In the rat, Northern blot hybridizations revealed three molecular sizes of
ODC
mRNA: 2.2, 2.7 and 1.6 kb. The levels of all molecular sizes were highest in stages VII-VIII, and the lowest mRNA levels were seen in stage I of the seminiferous epithelial cycle. The level of the 2.2 kb transcript was low during stages XIII-I. In the mouse, the Northern blot hybridizations also showed three molecular sizes of
ODC
mRNA: 2.2 and 2.7 kb and very low levels of 1.6 kb transcript. The levels of the transcripts were steady throughout the cycle. In the mouse, the 2.2 kb transcript was more abundant than the 2.7 kb transcript indicating a species difference between rat and mouse in the usage of the two polyadenylation signals within the
ODC
gene.(ABSTRACT TRUNCATED AT 250 WORDS)
Mol
Cell Endocrinol 1990 Oct 01
PMID:Stage- and cell-specific expression of the ornithine decarboxylase gene during rat and mouse spermatogenesis. 229 38
We have previously reported that testosterone decreased
ornithine decarboxylase
(
ODC
) activity in primary cultures of rat Sertoli cells. In this report we examined the mechanism of this reduction. In cells pretreated with testosterone (5 x 10(-7) M) for 48 h before the start of the experiment
ODC
activity was decreased, on the average, 43% at all time points examined.
ODC
mRNA levels were also decreased an overall 33%. The testosterone-mediated decrease in
ODC
activity was first seen 8 h after the addition of testosterone to the cells. Testosterone had no significant affect on the levels of actin or transferrin mRNA. The effect of testosterone was androgen specific. Neither
ODC
activity nor mRNA was affected by the nonandrogenic steroids progesterone or cortisol. These results suggest that testosterone decreases
ODC
mRNA in Sertoli cells either through an inhibition of transcription or through a decrease in message stability. Testosterone does not appear to affect
ODC
mRNA translation, since the percent decreases in
ODC
activity and mRNA in response to testosterone were essentially equivalent. Regulation of Sertoli cell
ODC
expression by testosterone may reflect one mechanism by which Sertoli cell function is integrated with surrounding cell types. The Sertoli cell, unlike any other cell, secretes putrescine, the product of
ODC
catalysis of ornithine. We suggest that the modulation of
ODC
by testosterone and, hence, the amount of putrescine secreted by the Sertoli cell may be significant in the process of spermatogenesis.
Mol
Endocrinol 1990 Aug
PMID:Testosterone decreases ornithine decarboxylase messenger RNA levels in primary cultures of rat Sertoli cells. 229 29
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>